USA
Beijing
India
MembershipGlobal Sickle Cell Disease Drug Market Research Report 2020
| Lowest Price Available | Length | Published Date | Report Id |
|---|---|---|---|
| from $2900.00 | 116 Pages | 2020-08-03 | 2040958 |
Summary:
The global Sickle Cell Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.This report focuses on Sickle Cell Disease Drug volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Sickle Cell Disease Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, etc.
Global Sickle Cell Disease Drug Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Sickle Cell Disease Drug Market: Regional Analysis
The research report includes a detailed study of regions of North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.
Global Sickle Cell Disease Drug Market: Competitive Landscape
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
Following are the segments covered by the report are:
ARQ-092
BIVV-003
CAL-H
CTX-001
DRX-194
Others
By Application:
Hospital
Clinic
Others
Key Players:
The Key manufacturers that are operating in the global Sickle Cell Disease Drug market are:
Acceleron Pharma Inc
Addmedica SAS
Angiocrine Bioscience Inc
Annexin Pharmaceuticals AB
ArQule Inc
Bio Products Laboratory Ltd
Bioverativ Inc
bluebird bio Inc
Bristol-Myers Squibb Co
Calimmune Inc
CRISPR Therapeutics
CSL Ltd
Daiichi Sankyo Co Ltd
Editas Medicine Inc
Errant Gene Therapeutics LLC
Gamida Cell Ltd
Genethon SA
Gilead Sciences Inc
Global Blood Therapeutics Inc
Competitive Landscape
The analysts have provided a comprehensive analysis of the competitive landscape of the global Sickle Cell Disease Drug market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.
Table of Contents
1 Sickle Cell Disease Drug Market Overview 1.1 Product Overview and Scope of Sickle Cell Disease Drug
1.2 Sickle Cell Disease Drug Segment by Type
1.2.1 Global Sickle Cell Disease Drug Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 ARQ-092
1.2.3 BIVV-003
1.2.4 CAL-H
1.2.5 CTX-001
1.2.6 DRX-194
1.2.7 Others
1.3 Sickle Cell Disease Drug Segment by Application
1.3.1 Sickle Cell Disease Drug Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Sickle Cell Disease Drug Market Size Estimates and Forecasts
1.4.1 Global Sickle Cell Disease Drug Revenue 2015-2026
1.4.2 Global Sickle Cell Disease Drug Sales 2015-2026
1.4.3 Sickle Cell Disease Drug Market Size by Region: 2020 Versus 2026
1.5 Sickle Cell Disease Drug Industry
1.6 Sickle Cell Disease Drug Market Trends
2 Global Sickle Cell Disease Drug Market Competition by Manufacturers
2.1 Global Sickle Cell Disease Drug Sales Market Share by Manufacturers (2015-2020)
2.2 Global Sickle Cell Disease Drug Revenue Share by Manufacturers (2015-2020)
2.3 Global Sickle Cell Disease Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Sickle Cell Disease Drug Manufacturing Sites, Area Served, Product Type
2.5 Sickle Cell Disease Drug Market Competitive Situation and Trends
2.5.1 Sickle Cell Disease Drug Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Sickle Cell Disease Drug Players (Opinion Leaders)
3 Sickle Cell Disease Drug Retrospective Market Scenario by Region
3.1 Global Sickle Cell Disease Drug Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Sickle Cell Disease Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Sickle Cell Disease Drug Market Facts & Figures by Country
3.3.1 North America Sickle Cell Disease Drug Sales by Country
3.3.2 North America Sickle Cell Disease Drug Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Sickle Cell Disease Drug Market Facts & Figures by Country
3.4.1 Europe Sickle Cell Disease Drug Sales by Country
3.4.2 Europe Sickle Cell Disease Drug Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Sickle Cell Disease Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Sickle Cell Disease Drug Sales by Region
3.5.2 Asia Pacific Sickle Cell Disease Drug Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Sickle Cell Disease Drug Market Facts & Figures by Country
3.6.1 Latin America Sickle Cell Disease Drug Sales by Country
3.6.2 Latin America Sickle Cell Disease Drug Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Sickle Cell Disease Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Sickle Cell Disease Drug Sales by Country
3.7.2 Middle East and Africa Sickle Cell Disease Drug Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Sickle Cell Disease Drug Historic Market Analysis by Type
4.1 Global Sickle Cell Disease Drug Sales Market Share by Type (2015-2020)
4.2 Global Sickle Cell Disease Drug Revenue Market Share by Type (2015-2020)
4.3 Global Sickle Cell Disease Drug Price Market Share by Type (2015-2020)
4.4 Global Sickle Cell Disease Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Sickle Cell Disease Drug Historic Market Analysis by Application
5.1 Global Sickle Cell Disease Drug Sales Market Share by Application (2015-2020)
5.2 Global Sickle Cell Disease Drug Revenue Market Share by Application (2015-2020)
5.3 Global Sickle Cell Disease Drug Price by Application (2015-2020)
6 Company Profiles and Key Figures in Sickle Cell Disease Drug Business
6.1 Acceleron Pharma Inc
6.1.1 Corporation Information
6.1.2 Acceleron Pharma Inc Description, Business Overview and Total Revenue
6.1.3 Acceleron Pharma Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Acceleron Pharma Inc Products Offered
6.1.5 Acceleron Pharma Inc Recent Development
6.2 Addmedica SAS
6.2.1 Addmedica SAS Corporation Information
6.2.2 Addmedica SAS Description, Business Overview and Total Revenue
6.2.3 Addmedica SAS Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Addmedica SAS Products Offered
6.2.5 Addmedica SAS Recent Development
6.3 Angiocrine Bioscience Inc
6.3.1 Angiocrine Bioscience Inc Corporation Information
6.3.2 Angiocrine Bioscience Inc Description, Business Overview and Total Revenue
6.3.3 Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Angiocrine Bioscience Inc Products Offered
6.3.5 Angiocrine Bioscience Inc Recent Development
6.4 Annexin Pharmaceuticals AB
6.4.1 Annexin Pharmaceuticals AB Corporation Information
6.4.2 Annexin Pharmaceuticals AB Description, Business Overview and Total Revenue
6.4.3 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Annexin Pharmaceuticals AB Products Offered
6.4.5 Annexin Pharmaceuticals AB Recent Development
6.5 ArQule Inc
6.5.1 ArQule Inc Corporation Information
6.5.2 ArQule Inc Description, Business Overview and Total Revenue
6.5.3 ArQule Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.5.4 ArQule Inc Products Offered
6.5.5 ArQule Inc Recent Development
6.6 Bio Products Laboratory Ltd
6.6.1 Bio Products Laboratory Ltd Corporation Information
6.6.2 Bio Products Laboratory Ltd Description, Business Overview and Total Revenue
6.6.3 Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Bio Products Laboratory Ltd Products Offered
6.6.5 Bio Products Laboratory Ltd Recent Development
6.7 Bioverativ Inc
6.6.1 Bioverativ Inc Corporation Information
6.6.2 Bioverativ Inc Description, Business Overview and Total Revenue
6.6.3 Bioverativ Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Bioverativ Inc Products Offered
6.7.5 Bioverativ Inc Recent Development
6.8 bluebird bio Inc
6.8.1 bluebird bio Inc Corporation Information
6.8.2 bluebird bio Inc Description, Business Overview and Total Revenue
6.8.3 bluebird bio Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.8.4 bluebird bio Inc Products Offered
6.8.5 bluebird bio Inc Recent Development
6.9 Bristol-Myers Squibb Co
6.9.1 Bristol-Myers Squibb Co Corporation Information
6.9.2 Bristol-Myers Squibb Co Description, Business Overview and Total Revenue
6.9.3 Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Bristol-Myers Squibb Co Products Offered
6.9.5 Bristol-Myers Squibb Co Recent Development
6.10 Calimmune Inc
6.10.1 Calimmune Inc Corporation Information
6.10.2 Calimmune Inc Description, Business Overview and Total Revenue
6.10.3 Calimmune Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Calimmune Inc Products Offered
6.10.5 Calimmune Inc Recent Development
6.11 CRISPR Therapeutics
6.11.1 CRISPR Therapeutics Corporation Information
6.11.2 CRISPR Therapeutics Sickle Cell Disease Drug Description, Business Overview and Total Revenue
6.11.3 CRISPR Therapeutics Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.11.4 CRISPR Therapeutics Products Offered
6.11.5 CRISPR Therapeutics Recent Development
6.12 CSL Ltd
6.12.1 CSL Ltd Corporation Information
6.12.2 CSL Ltd Sickle Cell Disease Drug Description, Business Overview and Total Revenue
6.12.3 CSL Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.12.4 CSL Ltd Products Offered
6.12.5 CSL Ltd Recent Development
6.13 Daiichi Sankyo Co Ltd
6.13.1 Daiichi Sankyo Co Ltd Corporation Information
6.13.2 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Description, Business Overview and Total Revenue
6.13.3 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Daiichi Sankyo Co Ltd Products Offered
6.13.5 Daiichi Sankyo Co Ltd Recent Development
6.14 Editas Medicine Inc
6.14.1 Editas Medicine Inc Corporation Information
6.14.2 Editas Medicine Inc Sickle Cell Disease Drug Description, Business Overview and Total Revenue
6.14.3 Editas Medicine Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Editas Medicine Inc Products Offered
6.14.5 Editas Medicine Inc Recent Development
6.15 Errant Gene Therapeutics LLC
6.15.1 Errant Gene Therapeutics LLC Corporation Information
6.15.2 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Description, Business Overview and Total Revenue
6.15.3 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Errant Gene Therapeutics LLC Products Offered
6.15.5 Errant Gene Therapeutics LLC Recent Development
6.16 Gamida Cell Ltd
6.16.1 Gamida Cell Ltd Corporation Information
6.16.2 Gamida Cell Ltd Sickle Cell Disease Drug Description, Business Overview and Total Revenue
6.16.3 Gamida Cell Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Gamida Cell Ltd Products Offered
6.16.5 Gamida Cell Ltd Recent Development
6.17 Genethon SA
6.17.1 Genethon SA Corporation Information
6.17.2 Genethon SA Sickle Cell Disease Drug Description, Business Overview and Total Revenue
6.17.3 Genethon SA Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Genethon SA Products Offered
6.17.5 Genethon SA Recent Development
6.18 Gilead Sciences Inc
6.18.1 Gilead Sciences Inc Corporation Information
6.18.2 Gilead Sciences Inc Sickle Cell Disease Drug Description, Business Overview and Total Revenue
6.18.3 Gilead Sciences Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.18.4 Gilead Sciences Inc Products Offered
6.18.5 Gilead Sciences Inc Recent Development
6.19 Global Blood Therapeutics Inc
6.19.1 Global Blood Therapeutics Inc Corporation Information
6.19.2 Global Blood Therapeutics Inc Sickle Cell Disease Drug Description, Business Overview and Total Revenue
6.19.3 Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.19.4 Global Blood Therapeutics Inc Products Offered
6.19.5 Global Blood Therapeutics Inc Recent Development
7 Sickle Cell Disease Drug Manufacturing Cost Analysis
7.1 Sickle Cell Disease Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Sickle Cell Disease Drug
7.4 Sickle Cell Disease Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Sickle Cell Disease Drug Distributors List
8.3 Sickle Cell Disease Drug Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Sickle Cell Disease Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Sickle Cell Disease Drug by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Sickle Cell Disease Drug by Type (2021-2026)
10.2 Sickle Cell Disease Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Sickle Cell Disease Drug by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Sickle Cell Disease Drug by Application (2021-2026)
10.3 Sickle Cell Disease Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Sickle Cell Disease Drug by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Sickle Cell Disease Drug by Region (2021-2026)
10.4 North America Sickle Cell Disease Drug Estimates and Projections (2021-2026)
10.5 Europe Sickle Cell Disease Drug Estimates and Projections (2021-2026)
10.6 Asia Pacific Sickle Cell Disease Drug Estimates and Projections (2021-2026)
10.7 Latin America Sickle Cell Disease Drug Estimates and Projections (2021-2026)
10.8 Middle East and Africa Sickle Cell Disease Drug Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Sickle Cell Disease Drug Sales (K Pcs) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Sickle Cell Disease Drug Sales (K Pcs) Comparison by Application: 2020 VS 2026
Table 3. Global Sickle Cell Disease Drug Market Size by Type (K Pcs) (US$ Million) (2020 VS 2026)
Table 4. Global Key Sickle Cell Disease Drug Manufacturers Covered in This Study
Table 5. Global Sickle Cell Disease Drug Sales (K Pcs) by Manufacturers (2015-2020)
Table 6. Global Sickle Cell Disease Drug Sales Share by Manufacturers (2015-2020)
Table 7. Global Sickle Cell Disease Drug Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Sickle Cell Disease Drug Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Sickle Cell Disease Drug Average Price (USD/Pcs) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Sickle Cell Disease Drug Sales Sites and Area Served
Table 11. Manufacturers Sickle Cell Disease Drug Product Types
Table 12. Global Sickle Cell Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Sickle Cell Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell Disease Drug as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Sickle Cell Disease Drug Players
Table 16. Global Sickle Cell Disease Drug Sales (K Pcs) by Region (2015-2020)
Table 17. Global Sickle Cell Disease Drug Sales Market Share by Region (2015-2020)
Table 18. Global Sickle Cell Disease Drug Revenue (Million US$) by Region (2015-2020)
Table 19. Global Sickle Cell Disease Drug Revenue Market Share by Region (2015-2020)
Table 20. North America Sickle Cell Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 21. North America Sickle Cell Disease Drug Sales Market Share by Country (2015-2020)
Table 22. North America Sickle Cell Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Sickle Cell Disease Drug Revenue Market Share by Country (2015-2020)
Table 24. Europe Sickle Cell Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 25. Europe Sickle Cell Disease Drug Sales Market Share by Country (2015-2020)
Table 26. Europe Sickle Cell Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Sickle Cell Disease Drug Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Sickle Cell Disease Drug Sales by Region (2015-2020) (K Pcs)
Table 29. Asia Pacific Sickle Cell Disease Drug Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Sickle Cell Disease Drug Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Sickle Cell Disease Drug Revenue Market Share by Region (2015-2020)
Table 32. Latin America Sickle Cell Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 33. Latin America Sickle Cell Disease Drug Sales Market Share by Country (2015-2020)
Table 34. Latin America Sickle Cell Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Sickle Cell Disease Drug Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Sickle Cell Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 37. Middle East and Africa Sickle Cell Disease Drug Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Sickle Cell Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Sickle Cell Disease Drug Revenue Market Share by Country (2015-2020)
Table 40. Global Sickle Cell Disease Drug Sales (K Pcs) by Type (2015-2020)
Table 41. Global Sickle Cell Disease Drug Sales Share by Type (2015-2020)
Table 42. Global Sickle Cell Disease Drug Revenue (Million US$) by Type (2015-2020)
Table 43. Global Sickle Cell Disease Drug Revenue Share by Type (2015-2020)
Table 44. Global Sickle Cell Disease Drug Price (USD/Pcs) by Type (2015-2020)
Table 45. Global Sickle Cell Disease Drug Sales (K Pcs) by Application (2015-2020)
Table 46. Global Sickle Cell Disease Drug Sales Market Share by Application (2015-2020)
Table 47. Global Sickle Cell Disease Drug Sales Growth Rate by Application (2015-2020)
Table 48. Acceleron Pharma Inc Sickle Cell Disease Drug Corporation Information
Table 49. Acceleron Pharma Inc Description and Business Overview
Table 50. Acceleron Pharma Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 51. Acceleron Pharma Inc Main Product
Table 52. Acceleron Pharma Inc Recent Development
Table 53. Addmedica SAS Sickle Cell Disease Drug Corporation Information
Table 54. Addmedica SAS Corporation Information
Table 55. Addmedica SAS Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 56. Addmedica SAS Main Product
Table 57. Addmedica SAS Recent Development
Table 58. Angiocrine Bioscience Inc Sickle Cell Disease Drug Corporation Information
Table 59. Angiocrine Bioscience Inc Corporation Information
Table 60. Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 61. Angiocrine Bioscience Inc Main Product
Table 62. Angiocrine Bioscience Inc Recent Development
Table 63. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Corporation Information
Table 64. Annexin Pharmaceuticals AB Corporation Information
Table 65. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 66. Annexin Pharmaceuticals AB Main Product
Table 67. Annexin Pharmaceuticals AB Recent Development
Table 68. ArQule Inc Sickle Cell Disease Drug Corporation Information
Table 69. ArQule Inc Corporation Information
Table 70. ArQule Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 71. ArQule Inc Main Product
Table 72. ArQule Inc Recent Development
Table 73. Bio Products Laboratory Ltd Sickle Cell Disease Drug Corporation Information
Table 74. Bio Products Laboratory Ltd Corporation Information
Table 75. Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Bio Products Laboratory Ltd Main Product
Table 77. Bio Products Laboratory Ltd Recent Development
Table 78. Bioverativ Inc Sickle Cell Disease Drug Corporation Information
Table 79. Bioverativ Inc Corporation Information
Table 80. Bioverativ Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Bioverativ Inc Main Product
Table 82. Bioverativ Inc Recent Development
Table 83. bluebird bio Inc Sickle Cell Disease Drug Corporation Information
Table 84. bluebird bio Inc Corporation Information
Table 85. bluebird bio Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. bluebird bio Inc Main Product
Table 87. bluebird bio Inc Recent Development
Table 88. Bristol-Myers Squibb Co Sickle Cell Disease Drug Corporation Information
Table 89. Bristol-Myers Squibb Co Corporation Information
Table 90. Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Bristol-Myers Squibb Co Main Product
Table 92. Bristol-Myers Squibb Co Recent Development
Table 93. Calimmune Inc Sickle Cell Disease Drug Corporation Information
Table 94. Calimmune Inc Corporation Information
Table 95. Calimmune Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Calimmune Inc Main Product
Table 97. Calimmune Inc Recent Development
Table 98. CRISPR Therapeutics Sickle Cell Disease Drug Corporation Information
Table 99. CRISPR Therapeutics Corporation Information
Table 100. CRISPR Therapeutics Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. CRISPR Therapeutics Main Product
Table 102. CRISPR Therapeutics Recent Development
Table 103. CSL Ltd Sickle Cell Disease Drug Corporation Information
Table 104. CSL Ltd Corporation Information
Table 105. CSL Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. CSL Ltd Main Product
Table 107. CSL Ltd Recent Development
Table 108. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Corporation Information
Table 109. Daiichi Sankyo Co Ltd Corporation Information
Table 110. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Daiichi Sankyo Co Ltd Main Product
Table 112. Daiichi Sankyo Co Ltd Recent Development
Table 113. Editas Medicine Inc Sickle Cell Disease Drug Corporation Information
Table 114. Editas Medicine Inc Corporation Information
Table 115. Editas Medicine Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Editas Medicine Inc Main Product
Table 117. Editas Medicine Inc Recent Development
Table 118. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Corporation Information
Table 119. Errant Gene Therapeutics LLC Corporation Information
Table 120. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Errant Gene Therapeutics LLC Main Product
Table 122. Errant Gene Therapeutics LLC Recent Development
Table 123. Gamida Cell Ltd Sickle Cell Disease Drug Corporation Information
Table 124. Gamida Cell Ltd Corporation Information
Table 125. Gamida Cell Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. Gamida Cell Ltd Main Product
Table 127. Gamida Cell Ltd Recent Development
Table 128. Genethon SA Sickle Cell Disease Drug Corporation Information
Table 129. Genethon SA Corporation Information
Table 130. Genethon SA Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 131. Genethon SA Main Product
Table 132. Genethon SA Recent Development
Table 133. Gilead Sciences Inc Sickle Cell Disease Drug Corporation Information
Table 134. Gilead Sciences Inc Corporation Information
Table 135. Gilead Sciences Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 136. Gilead Sciences Inc Main Product
Table 137. Gilead Sciences Inc Recent Development
Table 138. Global Blood Therapeutics Inc Sickle Cell Disease Drug Corporation Information
Table 139. Global Blood Therapeutics Inc Corporation Information
Table 140. Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 141. Global Blood Therapeutics Inc Main Product
Table 142. Global Blood Therapeutics Inc Recent Development
Table 143. Sales Base and Market Concentration Rate of Raw Material
Table 144. Key Suppliers of Raw Materials
Table 145. Sickle Cell Disease Drug Distributors List
Table 146. Sickle Cell Disease Drug Customers List
Table 147. Market Key Trends
Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 149. Key Challenges
Table 150. Global Sickle Cell Disease Drug Sales (K Pcs) Forecast by Type (2021-2026)
Table 151. Global Sickle Cell Disease Drug Sales Market Share Forecast by Type (2021-2026)
Table 152. Global Sickle Cell Disease Drug Revenue (Million US$) Forecast by Type (2021-2026)
Table 153. Global Sickle Cell Disease Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 154. Global Sickle Cell Disease Drug Sales (K Pcs) Forecast by Application (2021-2026)
Table 155. Global Sickle Cell Disease Drug Revenue (Million US$) Forecast by Application (2021-2026)
Table 156. Global Sickle Cell Disease Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 157. Global Sickle Cell Disease Drug Sales Market Share Forecast by Region (2021-2026)
Table 158. Global Sickle Cell Disease Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 159. Global Sickle Cell Disease Drug Revenue Market Share Forecast by Region (2021-2026)
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Sickle Cell Disease Drug
Figure 2. Global Sickle Cell Disease Drug Sales Market Share by Type: 2020 VS 2026
Figure 3. ARQ-092 Product Picture
Figure 4. BIVV-003 Product Picture
Figure 5. CAL-H Product Picture
Figure 6. CTX-001 Product Picture
Figure 7. DRX-194 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Sickle Cell Disease Drug Consumption Market Share by Application: 2020 VS 2026
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Sickle Cell Disease Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Sickle Cell Disease Drug Sales Capacity (K Pcs) (2015-2026)
Figure 15. Global Sickle Cell Disease Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Sickle Cell Disease Drug Sales Share by Manufacturers in 2020
Figure 17. Global Sickle Cell Disease Drug Revenue Share by Manufacturers in 2019
Figure 18. The Global 5 and 10 Largest Players: Market Share by Sickle Cell Disease Drug Revenue in 2019
Figure 19. Sickle Cell Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Sickle Cell Disease Drug Sales Market Share by Region (2015-2020)
Figure 21. Global Sickle Cell Disease Drug Sales Market Share by Region in 2019
Figure 22. Global Sickle Cell Disease Drug Revenue Market Share by Region (2015-2020)
Figure 23. Global Sickle Cell Disease Drug Revenue Market Share by Region in 2019
Figure 24. North America Sickle Cell Disease Drug Sales Market Share by Country in 2019
Figure 25. North America Sickle Cell Disease Drug Revenue Market Share by Country in 2019
Figure 26. U.S. Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 27. U.S. Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Canada Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 29. Canada Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. Europe Sickle Cell Disease Drug Sales Market Share by Country in 2019
Figure 31. Europe Sickle Cell Disease Drug Revenue Market Share by Country in 2019
Figure 32. Germany Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 33. Germany Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. France Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. France Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. U.K. Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.K. Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Italy Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Italy Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Russia Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Russia Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Asia Pacific Sickle Cell Disease Drug Sales Market Share by Region in 2019
Figure 43. Asia Pacific Sickle Cell Disease Drug Revenue Market Share by Region in 2019
Figure 44. China Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. China Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Japan Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Japan Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. South Korea Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. South Korea Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. India Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. India Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Australia Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Australia Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Taiwan Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Taiwan Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Indonesia Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Indonesia Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Thailand Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. Thailand Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Malaysia Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Malaysia Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Philippines Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Philippines Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Vietnam Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Vietnam Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Latin America Sickle Cell Disease Drug Sales Market Share by Country in 2019
Figure 67. Latin America Sickle Cell Disease Drug Revenue Market Share by Country in 2019
Figure 68. Mexico Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Mexico Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Brazil Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Brazil Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Argentina Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Argentina Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Middle East and Africa Sickle Cell Disease Drug Sales Market Share by Country in 2019
Figure 75. Middle East and Africa Sickle Cell Disease Drug Revenue Market Share by Country in 2019
Figure 76. Turkey Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Turkey Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Saudi Arabia Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Saudi Arabia Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. U.A.E Sickle Cell Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. U.A.E Sickle Cell Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Sales Market Share of Sickle Cell Disease Drug by Type (2015-2020)
Figure 83. Sales Market Share of Sickle Cell Disease Drug by Type in 2019
Figure 84. Revenue Share of Sickle Cell Disease Drug by Type (2015-2020)
Figure 85. Revenue Market Share of Sickle Cell Disease Drug by Type in 2019
Figure 86. Global Sickle Cell Disease Drug Sales Growth by Type (2015-2020) (K Pcs)
Figure 87. Global Sickle Cell Disease Drug Sales Market Share by Application (2015-2020)
Figure 88. Global Sickle Cell Disease Drug Sales Market Share by Application in 2019
Figure 89. Global Revenue Share of Sickle Cell Disease Drug by Application (2015-2020)
Figure 90. Global Revenue Share of Sickle Cell Disease Drug by Application in 2020
Figure 91. Acceleron Pharma Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Addmedica SAS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Angiocrine Bioscience Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Annexin Pharmaceuticals AB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. ArQule Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Bio Products Laboratory Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Bioverativ Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. bluebird bio Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Bristol-Myers Squibb Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Calimmune Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. CRISPR Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. CSL Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Daiichi Sankyo Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Editas Medicine Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Errant Gene Therapeutics LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Gamida Cell Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Genethon SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Gilead Sciences Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Global Blood Therapeutics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Price Trend of Key Raw Materials
Figure 111. Manufacturing Cost Structure of Sickle Cell Disease Drug
Figure 112. Manufacturing Process Analysis of Sickle Cell Disease Drug
Figure 113. Sickle Cell Disease Drug Industrial Chain Analysis
Figure 114. Channels of Distribution
Figure 115. Distributors Profiles
Figure 116. Porter's Five Forces Analysis
Figure 117. North America Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 118. North America Sickle Cell Disease Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Europe Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 120. Europe Sickle Cell Disease Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 121. Latin America Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 122. Latin America Sickle Cell Disease Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 123. Middle East and Africa Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 124. Middle East and Africa Sickle Cell Disease Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 125. Asia Pacific Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 126. Asia Pacific Sickle Cell Disease Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
Global Recombinant Collagen Market Insights, Forecast to 2028
Published Date: 2022-05-27 | Pages: 89 | Tables: 115
USD 4,900 （Single License） USD 9,800 （Enterprise License）
Global Fat Emulsion Injection Market Insights, Forecast to 2028
Published Date: 2022-05-27 | Pages: 113 | Tables: 134
USD 4,900 （Single License） USD 9,800 （Enterprise License）
Global Amino Acid Injection Market Insights, Forecast to 2028
Published Date: 2022-05-27 | Pages: 115 | Tables: 148
USD 4,900 （Single License） USD 9,800 （Enterprise License）
Global Basic Infusion Medicament Market Insights, Forecast to 2028
Published Date: 2022-05-27 | Pages: 115 | Tables: 146
USD 4,900 （Single License） USD 9,800 （Enterprise License）
Global Basic Infusion Market Insights, Forecast to 2028
Published Date: 2022-05-27 | Pages: 114 | Tables: 144
USD 4,900 （Single License） USD 9,800 （Enterprise License）
